BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37345735)

  • 1. Somatic loss of ATM is a late event in pancreatic tumorigenesis.
    Paranal RM; Jiang Z; Hutchings D; Kryklyva V; Gauthier C; Fujikura K; Nanda N; Huang B; Skaro M; Wolfgang CL; He J; Klimstra DS; Brand RE; Singhi AD; DeMarzo A; Zheng L; Goggins M; Brosens LA; Hruban RH; Klein AP; Lotan T; Wood LD; Roberts NJ
    J Pathol; 2023 Aug; 260(4):455-464. PubMed ID: 37345735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants.
    Hutchings D; Jiang Z; Skaro M; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Zheng L; Klimstra DS; Brand RE; Singhi AD; Goggins M; Klein AP; Roberts NJ; Hruban RH
    Mod Pathol; 2019 Dec; 32(12):1806-1813. PubMed ID: 31285527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
    Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M
    Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Nanda N; Roberts NJ
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31963441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.
    Fujikura K; Alruwaii ZI; Haffner MC; Trujillo MA; Roberts NJ; Hong SM; Macgregor-Das A; Goggins MG; Roy S; Meeker AK; Ding D; Wright M; He J; Hruban RH; Wood LD
    J Pathol; 2021 Jul; 254(3):279-288. PubMed ID: 33870509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
    Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
    J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic
    Hannan Z; Yu S; Domchek S; Mamtani R; Reiss KA
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms.
    Skaro M; Nanda N; Gauthier C; Felsenstein M; Jiang Z; Qiu M; Shindo K; Yu J; Hutchings D; Javed AA; Beckman R; He J; Wolfgang CL; Thompson E; Hruban RH; Klein AP; Goggins M; Wood LD; Roberts NJ
    Gastroenterology; 2019 May; 156(6):1905-1913. PubMed ID: 30716324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia.
    Brody JR; Witkiewicz A; Williams TK; Kadkol SS; Cozzitorto J; Durkan B; Pasternack GR; Yeo CJ
    Mod Pathol; 2007 Dec; 20(12):1238-44. PubMed ID: 17906614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians.
    Klöppel G; Lüttges J
    Curr Gastroenterol Rep; 2004 Apr; 6(2):111-8. PubMed ID: 15191688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of Pancreatic Cancer Precursor Lesions.
    Noë M; Brosens LA
    Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
    El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
    J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
    Fischer CG; Wood LD
    J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer.
    Drosos Y; Escobar D; Chiang MY; Roys K; Valentine V; Valentine MB; Rehg JE; Sahai V; Begley LA; Ye J; Paul L; McKinnon PJ; Sosa-Pineda B
    Sci Rep; 2017 Sep; 7(1):11144. PubMed ID: 28894253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
    Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
    Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K
    J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.